Влияние блокатора рецепторов ангиотензина II и его комбинации с диуретиком на структурно-функциональное состояние миокарда, функцию почек и суточный профиль АД у больных гипертонической болезнью
Диссертация
Длительная терапия лозартаном и его комбинация с ГХТ у больных ГБ оказывает кардиопротективный эффект в виде уменьшения выраженности ГЛЖ, улучшения геометрии и диастолической функции ЛЖ. Регресс ГЛЖ на фоне лечения определялся исходной её выраженностью и типом проводимой терапиидостоверной корреляционной связи между регрессом ГЛЖ и антиги-пертензивным эффектом не выявлено. Положительная динамика… Читать ещё >
Список литературы
- Арабидзе Г. Г. Гипертоническая болезнь.//В кн.: Руководство по кардиологии /Под ред. Е. И. Чазова. М.: Медицина, 1992- Т. З:147−195.
- Арабидзе Г. Г., Белоусов Ю. Б., Варакин Ю. Я., и др. Диагностика и лечение артериальной гипертонии (Методические рекомендации). Москва, 1997: С. 95.
- Барац С.С., Закроева А. Г. Диастолическая дисфункция сердца по показателям трансмитрального кровотока и потока в лёгочных венах: дискуссионные вопросы патогенеза, терминологии и классификации. Кардиология 1998 № 5 стр. 69−76.
- Беленков Ю.Н., Мареев В. Ю. Принципы рационального лечения сердечной недостаточности. Москва 2000 г.
- Бувальцев В.И. Суточные колебания артериального давления и особенности его формирования дневное и ночное время суток при гипертонической болезни. Автореф дисс кенд мед наук М, 1988:26.
- Волков B.C., Мазур Е. С., Мазур В. В. О клиническом значении уменьшения ночного снижения артериального давления у больных гипертонической болезнью. Кардиология 1999,12.32−34.
- Глотов М.Н., Мазур Н. А. Диастолическая функция ЛЖ у больных гипертонической болезнью. Кардиология 1994- 1:89−93.
- Горбунов В.М. Значение 24-часового мониторирования в выявлении и лечении артериальной гипертензии. Кардиология 1995−6:64−70.
- Горбунов В.М. Значение исследования различных видов вариабельности артериального давления у больных с артериальной гипертензией. Кардиология 1997−1:66−69.
- Горбунов В.М., Савина Л. В., Метелица В. И., Деев А. Д. Оценка равномерности антигипертензивного эффекта лозартана и каптоприла с помощью 24-часового мониторирования артериального давления. Терапевтический архив- 2001−2:38−43.
- Гургенян С.В., Микаелян Е. С., Оганесян А. Н. Перфузионно-метаболические и функциональные изменения гипертрофированного левого желудочка у больных артериальной гипертонией. Журн экспер клин мед 1989−1:31−35.
- Дядык АИ, Багрий АЭ, Лебедь ИА, Яровая НФ. Патогенез гипертрофии левого желудочка сердца у больных артериальными гипертониями. Кардиология № 1 1995г, с.59−63.
- Жаров Е.И., Верткин А. Л., Соловьёв В В. Длительное мониторирование артериального давления. Кардиология, 1990−6:118−122.
- Зелвеян П.А., Ощепкова Е. В., Буниатян М. С. и соавт. Суточный ритм артериального давления и состояние органов-мишеней у больных с мягкой и умеренной формами гипертонической болезни. Тер. Архив, 2001,2:33−38.
- Карпов Р.С., Павлюкова Е. Н., Мордовии В.Ф и др. Изучение перфузии миокарда у больных гипертонической болезнью. Кардиология 1992−3:40−42.
- Карпов Р.С., Пузырёв К. В., Павлюкова Е. Н. и др. Молекулярно-генетический анализ гипертрофии левого желудочка. Кардиология 2001−6:25
- Кобалава Ж.Д. Клиническое и фармакологическое обоснование выбора антигипертензивных препаратов у больных эссенциальной гипертонией с сопутствующими факторами риска. Дисс. Док. Мед. Наук. М. 1997.
- Кобалава Ж.Д. Международные стандарты по артериальной гипертонии: согласованные и несогласованные позиции. Кардиология 1999−11:78−91.
- Кобалава Ж.Д., Ивлева А. Я., Котовская Ю. В. и др. Особенности суточного профиля АД у больных гипертонической болезнью с метаболическими нарушениями. Клин фармакол и тер, 1995−5:42.
- Кобалава Ж.Д., Котовская Ю. В. Артериальная гипертония 2000. Москва 2001 г стр. 83.
- Кобалава Ж. Д Эволюция комбинированной антигипертензивной терапии: от многокомпонентных высокодозовых свободных комбинаций до низкодозо-вых фиксироанных комбинаций как средств первого выбора. Российский медицинский журнал, 2001,9:18- 789−795.
- Кобалава Ж.Д., Котовская Ю. В., Моисеев B.C. Особенности утреннего подъёма артериального давления у больных гипертонической болезнью с различными вариантами суточного ритма. Кардиология 1999−6:23−26.
- Кобалава Ж.Д., Котовская Ю. В., Терещенко С. Н. и др. Клиническое значение суточного мониторирования артериального давления для выбора тактики лечения больных артериальной гипертонией. Кардиология, 1997−9:98−104.
- Конради А.О., Захаров Д. В., Галявич АС. Влияние лозартана на показатели вариабельности сердечного ритма и гипертрофию левого желудочка у больных гипертонической болезнью. 1 конгресс кардиологов СНГ. Тезисы. Стр. 207.
- Котовская Ю.В. Варианты суточных ритмов АД при гипертонической болезни и влияние на них ингибитова АПФ фозиноприла, антагониста рецепторов к ангиотензину 11 лозартана и диуретика индапамида. Дисс канд. Мед. Наук М. 1997.
- Куджини П, Кавасаки Т, Ди Патша J1 и др. Циркадиый ритм артериального давления: хронобиологические критерии нормотонии и гипертонии. Физиология человека. 1994-том 17:73−79.
- Леонова М.В., Белоусов Ю. Б., Семенчук Г. А. и др. Анализ показателей амбулаторного суточного мониторирования артериального давления у больных артериальной гипертонией. Тер. Архив, 1997−1:35−38.
- Лукутина Л.В. Суточные колебания некоторых показателей гемодинамики и активности ренин-ангиотензин-альдостероновой системы при гипертонической болезни и почечных артериальных гипертониях. Автореф дисс канд мед наук, Т, 1987.
- Мазур Е.С., Калязина В В. О клиническом значении вариабельности артериального давления при гипертонической болезни. Тер архив, 1999−1:22−25.
- Малышева Е.А., Леонова М. В., Прошин А. Ю. и соавт. Влияние амлодипина на массу миокарда левого желудочка и показатели центральной гемодинамики у больных с артериальной гипертонией и атеросклерозом сонных артерий. Клин. Фермакол. Тер., 1997,6(3):29−32.
- Мартынов А.И., Степура О Б., Иванова С В. и соавт. Ремоделирование и диастолическая функция левого желудочка сердца у больных с атрериальной гипертензией (по материалам XVII-XXI конгрессов Европейского общества кардиологов) Кардиология 2001−7:67−70.
- Оганов Р.Г. Смертность от сердечно-сосудистых заболеваний в России и некоторые влияющие на неё факторы. Кардиология, 1994−4:80−88.
- Ольбинская Л.И., Мартынов А. И., Хапаев Б. А. Мониторирование артериального давления в кардиологии. М. 1998:30.
- Ощепкова Е.В., Рогоза А. Н., Варакин Ю. А. Вариабельность артериального давления (по данным 24-часового мониторирования) при мягкой артериальной гипертоник. Тер. Архив, 1994−8:70−75.
- Ощепкова Е.В., Лазарева Н. В., Филатова Л. В. и соавт. Утренний подъём артериального давления (по данным суточного мониторирования АД) и агрегация тромбоцитов у больных гипертонической болезнью. Тер. Архив. 2000−4:47−51.
- Преображенский Д.В., Сидоренко Б. А., Сополева Ю. З. Иосава И.К. Физиология и фармакология ренин-ангиотензиновой системы. Кардиология 1997 № 11, с. 91−95.
- Рогоза А.Н., Никольский В. П., Ощепкова Е. В. и др. Суточное мониториро-вание артериального давления (Методические вопросы). Под ред. Г. Г. Арабидзе и О. Ю. Атькова. М. 1997.
- Сидоренко Б.А., Иосава И. К., Киктев В. Г., Преображенский Д. В. Блокаторы ATI ангиотензиновых рецепторов как новая группа антигипертензивных препаратов. Клиническая фармакология и терапия. 1999−8:38−45.
- Скворцов А.А., Мареев В. Ю., Беленков ЮН. Блокаторы рецепторов ангиотензина 11 (механизмы действия, первые клинические результаты). Кардиология 1998−4:36−50.
- Титов В.Н., Тарасов А. В. Микроальбуминурия: патофизиология, диагностическое значение и методы исследования. Тер. Архив 1988- 134−140.
- Тиц Н. У. Клиническая оценка лабораторных тестов: пер. с англ. М.: Медицина, 1986.-479.
- Фофанова Т.Ф., Юренев А. П. «Немая» ишемия миокарда при артериальной гипертонии. Кардиология 1992−9:70−74.
- Хапаев Б.А. Влияние антагонистов кльция пролонгированного действия на циркадианный ритм и вариабельность артериального давления в течение суток у больных мягкой и умеренной артериальной гипертензией. Дисс канд. Мед наук. 1995.
- Шатрова Г. О., Ощепкова Е. В., Рогоза А. Н. и соавт. Барорецепторный контроль и суточная вариабельность АД у больных «мягкой» артериальной гипертонией и гемодинамически незначимым атеросклеротическим поражением сонных артерий. Кардиология, 1992- 11:11−18.
- Шляхто Е.В., Конради А. О., Захаров Д. В., Рудоманов О. Г. Структурно-функциональные изменения миокарда у больных гипертонической болезнью. Кардиология 1999, № 2, стр. 49−55.
- Шевцов М.Ю. Блокаторы рецепторов ангиотензика All- первый опыт и перспективы применения в нефрологии. Тер. Архив 2000−6:73−79.
- Шулутко Б.И. Почки и гипертензия. Тер. Архив, 1987−8:26−29.
- Шхвацабая И.К., Юренев А. П. Гипертоническое сердце. Кардиология, 1988−12:5−9.
- Юренев А.П., Нестерова A.JI., Береснева З. В. Влияние длительного амбулаторного гипотензивного лечения на структрно-функциональное состояние миокарда. Кардиология 1985−4:64−67.
- Юренев А.П. Клинико-функциональная характеристика сердца при гипертонической болезни. Дис. Д-ра мед. Наук.
- Контроль артериального давления и прогрессирование хронической почечной недостаточности. Международные направления в исследовании артериальной гипертензии. 2000,10:2−3.
- Нефрология. Руководство для врачей. В 2 томах. Под редакцией И.Е. Та-реевой. Москва «Медицина» 1995- том 1, стр 176.
- Agabiti-Rosel Е. Evaluation of cardiac effects of antihypertensive agents. J of Cardiovascular Pharmacology. 1994−23:42−4S.
- Agewall S, Persson B, Samuelsson O. Microalbuminuria in treated hypertensive men at high risk of coronary disease. J Hypertens 1993−11-.461−469.
- Alderman MH. Which antihypertensive drugs first-and why? JAMA 1992- 267:2786−87.
- Alii C, Lombardo M, Zanni D et al. Albuminuria and transferrinuria in essential hypertension. Effects of antihypertensive therapy. Am J Hypertens 1996−9:1068−76.
- Almazov VA, Shlyakhto EV, Conrady AO et al. Correlation of hypertensive cardiac remodeling: comparison of different antihypertensive therapies. J Hypertens 1999−17:3:194.
- Asmar R, Brunei P, Pannier В et al. Arterial distensibility and ambulatory blood pressure monitoring in essential hypertension. Am J Cardiol 1988−1:1066−1070.
- Bakris GL. Effects of diltiazem or lisinopril on massive proteinuria with diabetes mellitus. Ann Intern Med 1990−122:707−8.
- Balogun M, Dunn F. Systolic and diastolic function following regression of left ventricular hypertrophy in hypertension. J Hypertens 1991 -9(5):21 -26.
- Bauer J, Reams G. The angiotensin II type I receptor antagonists: a new class of antihypertensive drugs. Arch Intern Med 1995−155:1361−1368.
- Bauwens F, Duprez D, Buyzere M et al. Diastiolic blood pressure load is the best predictor for left ventricular hypertrophy in moderate essential arterial hypertension. 5-European Meeting of Hypertension. Milan 1993. Abstr. 53.
- Bauwens F, Duprer D, De Buyrere M. Influence of the arterial blood pressure and nonhemodinamic factors о left ventricular hypertrophy in moderate essential hypertension. Am J Cardiol 1991−68:925−29.
- Benetos A, Rudnichi A, Safar M et al. Pulse pressure and cardiovascular mortality in normotensive subjects. Hypertension, 1998−32:560−64.
- Beltman F, Heesen W, Smit A. Two-year follow-up study to evaluate the reduction of left ventricular mass and diastolic function in mild to moderate diastolic hypertensive patients. J Hypertens 1998,16:6:15−19.
- Bianchi S, Bigazzi R, Baldari G et al. Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs. Am J Med 1992−93:525−8.
- Bignotti M. Effects of chronic treatment with the АЛ antagonist losartan on LV anatomy and function and microalbuminuria in hypertensives. Abstract: P32, Milan 13−16 June 1997.
- Bikkina M, Levy D, Evans JC, Larson MG, Benjamin EJ, Wolf PA, Castelli WP. Left ventricular mass and the risk the stroke in elderly cohort: The Framingham Study. JAMA 1994- 272: 33−36.
- Brevetti G et al. 24-hour blood pressure recording in patients with orthostatic hypotension. Clin. Cardiol., 1985−8:406−412.
- Brezinski DA, Tofler GH, Muller JE et al. Morning increase in platelet aggrega-bility. Association with assumption of the upright posture. Circulation, 1988−78:35−40.
- Broadhurst P, Kelleher C, Hughes L et al. Fibrinogen, factor VII clotting activity, and coronary artery disease severity. Aterosclerosis. 1990,85:169−173.
- Brutsaert DL. Analysis of relaxation in the evaluation of ventricular function of the heart. Progr Cardiovasc Dis 1985−28:143.
- Brenner B, Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int. 1983−23:647−655.
- Schmieder RE, Messerli FH et al. Glomerular hyperfiltration indicates erly tar-gert organ damage in essential hypertension. JAMA 1990,264:2775−80.
- O’Brien E, Sheridan J, O’Malley K. Dippers and non-dippers (letter). Lancet 1988−2:700−702.
- Booz GW, Dostal DE, Baker KM. Paracrine action of cardiac fibroblasts on cardiomyocytes: implications for the cardiac renin-angiotensin system. Am J Card 1999−83:44−47.
- Burt VL, Cutler JA et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Data from the Health examination surveys. 960−1991. Hypertension. 1995−26:60−9.
- Camprese VM. Clinical aspects and management of essential hypertension. In Textbook of Nephrology. Edited by Massry SG, Glassock RJ, Baltimor, Maryland: Williams and Wilkins- 1995:1186−1217.
- Carmona J, Vasconcelos N, Amado P et al. Blood pressure morning rise profile in hypertensive patients and controls evaluated by ambulatory blood pressure monitoring. Abstracts of the VII th European meetting on hypertension 1992:33.
- Carusio D, D’Isanto F, Del Piano C. Effect of ATl-reseptor inhibitor losartn on impared diastolic filling in human hypertension. J Hypertens 19 999−17(3):219.
- Castellot JJJ, Addonizio ML, Rosenberg R et al. Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J Cell Biol 1981−90:372−9.
- Cerasola G, Cottone S, Mule G et al. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J of hypertension 1996−14:915−920.
- Clement D, Calardyn F, Packert L et al. Ambulatory blood pressure monitoring. Newport Beach, Calif., 1983:21−27.
- Cheung B. Incresed LV mass after losartan treatment. The Lancet. Vol 349. June 14,1997.
- Collins R, Pete R. Antihypertensive drug therapy: effects on stroke and coronary heart disease. In: Swales JD, ed. Textbook of Hypertension. Oxford: Blackwell Publications, 1994:1156−1164.
- Collins R, Peto R, MacMahon S et al. Blood pressure, stroke, and coronary heart disease. Part 2- short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990- 335:827−38.
- Conway J, Boon N, Jones J. Mechanisms concened with blood pressure variability throught the day. Clin and exper.-theory and practice. 1985-A7:153−157.
- Cooper RS, Simmons B, Castaner A et al. Left ventricular hypertrophy is associated with worse survival independent of left ventricular function and coronary arteries severy narroved. Am J Cardiol. 1990.65:441−445.
- Critchey JA, Chan J, Lappe JT et al. Antihypertensive and antialbuminuric effects and tolerability of losartan potassum compared to felodipine-ER in elderly hypertensive patients. Ibid- 19−20.
- Cruickshank J, Lewis J, Moore V, Dodd C. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 1992−6:85−90.
- Cuocolo A, Sax FL, Brush JE et al. Left ventricular hypertrophy and impaired diastolic filling in essential hypertension. Circulation 1990−81:978−986.
- Cuspidi C, Lonati L, Sampieri L et al. Effects of losartan on blood pressure and LV mass in essential hipertension. High Blood Press. 1998−7:75−79.
- Dahlof B, Pennert K, Hannson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. AM J Hypertens 1992−5:95−110.
- Dejong PE, de Zeeuw D. Renoprotective therapy, titration against urinary protein excretion. Lancet 1999- 354:352−3.
- Deckert T, Feldt RB, Borch Ж et al. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetiolgia 1989. 32:219−26.
- Devereux RB, Reicheck N. Echocardiography determinstion of left ventricular mass in man: anatomic validation of the method. Circulation 1977,55:613−618.
- Devereux R.B. Theraperutic options in minimizing LVH. Am Heart J 2000- 139: S9-S14.
- Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography: anatomic validation, standardization, and comparison to other methods. Hypertension. 1987−9(П): 19−26.
- Devereux RB Do Antihypertensive drugs differ in their ability to regress left ventricular hypertrophy? Circulation 1997- 95:1983−1985.
- Devereux RB, Agabiti-Rosei E, Dahlof B, Grosse P, Hahn RT, Okin PM, Roman Ш. Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials. J Hypertens. 1996- 14:95−102.
- Devereux RB, Dahlof B. Criteria for informative trial of LVH regression. J Hum Hypertens 1994- 8:735−9.
- Devereux R, James G, Pickering Th. What is normal blood pressure? Comparison of ambulatory pressure level and variability in patients with normal or abnormal left ventricular geometry. Am J Hypertens. 1993−6:211−215.
- Devereux RB, Okin PM, Roman MJ Pre-clinical cardiovascular disease and surrogate end-points in hypertension: does race influence target organ damange independent of blood prassure? Ethn Dis 1998- 8:138−48.
- Devereux R.B., Pini R, Aurigemma GP, Roman MJ. Measurement of LV mass: methodology and expertise. J hypertens 1997,15:801−809.
- Devereux RB, Pickering TG, Harschfieid GA et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 1988−68:470−76.
- Devereux R, Pickering Th. Relationship between ambulatory and exercise blood pressure and cardiac structure. Am Heart J 1988−116:1124−1133.
- Devereux R, Pickering Th, Alderman M. Left ventricular hypertrophy in hypertension. J Hypertens 1987−9:1153−1160.
- Drayer J, Weber M. Definition of normalcy in whole-day ambulatory blood pressure monitoring. Clin and exper theory and practice 1985−7:195−204.
- Drayer J, Weber M, De Young J et al. Long-term blood pressure monitoring in the evaluation of antihypertensive therapy. Arch Intern Med 1983−143:898−901.
- Drayer J, Weber M, Nakamura D. Automated ambulatory blood pressure monitoring: A study of age-matched normotensive and hypertensive men. Am Heart J 1985−109:1334.
- Eliahou HE, Cohen D, Hellberg B. Effect of the calcium channel blocker nisoldipine on the progression of chronic renal falure in man. Am J Nephrol 1988−8:285−90.
- Epstein M, Parving HH, Ruilop LM. Surrogat endpoints and renal pritection: focus on microalbuminuria. Blood Pressure 1997−6:52−57.
- Erley C, Haefele U, Heyne N et al. Microalbuminuria in essential hypertension: reduction by different antihypertensive drugs. Hypertension 1993−21:810−815.
- Fagard RH, Staessen JA, Thijs L. Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy. J of Hypertension 1997,15:1493−1502.
- Franklin SS, Khan SA, Wong ND et al. Is puis pressure more important then systolic blood pressure in predicting coronary heart disease events. Circulation 1999−100:354−60.
- Fratolla A, Parati G, Cuspidi С et al. Prognostic value of 24-hour pressure variability. J Hypertens, 1993−11:1133−1137.
- Friedman R et al. In press 1980.
- Frohlich ED, Apstein C, Chobanian AV et al. The heart in hypertension. N Engl J Med 1992−327:998−1008/
- Folkow B, Hallbaeck M, Lundgren Y et al. Background of increased flow resistance and vascular reactivity in spontaneously hypertensive rats. Acta Physiol Scand 1974−91:103−15.
- Gaasch WH, Bing OH, Mirsky I Eur Heart J 1982−3:139−145.
- Gansevoort RT, De Zeeuw D, Shahinfar S et al. Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease. J Hypertens 1994- 12:3742.
- Ganau A, Devereux RB, Roman MJ et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992−19:1550−1558.
- Ghali Ж, Liao Y, Cooper RS. Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol 1998−31:1635−40.
- Gianconi S, Levant C, Fommei E et al. Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 1989−2:259−261.
- Gottdiener JS, Livengood V et al. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of LVM and function. J Am Coll Cardiol 1995−25:424−30 .
- Gottdiener JS, Reda D, Notargiacomo A, Masterson B. Comparison of monotherapy effects on LV mass regression in mild-to-moderate hypertention: differences between short and long- term therapy. J Am Coll Cardiol 1992- 19:85 Abstract.
- Gottdiener JS, Reda D et al. Effects of single-drug therapy on reduction of LV mass in mild to moderate hypertention: Comparison of six antihypertensive agents. Circulation 1997−95:2007−2014.
- Graettinger WF, Brug RJ. Left ventricular diastolic function and hypertension. Cardiol Clin 1995- 13.559−567.
- Gradman AH, Arcuri KE, Goldberg Al et al. A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleat in patients with essential hypertension. 1995−25:1345−1350.
- Grossman W. Diastolic dy si unction and congestive heart failure. Circulation 1990−81:1−7.
- Grossman W. Defining diastolic function. Circulation. 2000−101:2020−2022.
- Gruden G, Cavallo PP, Bazzan M et al. PA-I and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 1994−43:426−9.
- Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, Laragh JH. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hipertension. Am J Cardiol 1986- 7:639−650.
- Haflher SM, Stem MP, Gruber MK et al. Microalbuminuria. Potential marker for increased cardiovascular risk factors in non-diabetic subjects? Arteriosclerosis 1990- 10:727−31.
- Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998−351:1755−62.
- Harald H, Mullner M, Domanovits H et al. Use of an age-adjusted Doppler E/A ratio in patients with moderate to severe hypertension. J of Hypertension 2000,18:1477−1481.
- Harrap SB, Dominiczak AF et al. Plasma All predisposition to hypertension, and LV size in healthy young adults. Circulation 1996−93:1148−54.
- Hayakawa H, Coffee K, Guerra J t al. Cardio-renal protective effects of the angiotensin П receptor antagonist, irbesartan, in salt-sentitive hypertension. Ibid 1997.
- Herkner H, Mullner M, Domaovits H et al. Use of an age-adjusted Doppler E/A ratio in patients with moderate to severe hypertension. J of Hypertens. 2000,18:147 781.
- Horan M, Kennedy H et al. Do boderline hypertensive patients have labile blood pressure? Arch Intern Med 1981−94:466.
- Imai Y, Abe K, Miura Y et al. Hypertensive episodes and circadian fluctuations of blood pressure in patients with pheochromocytoma: studies by long-term blood pressure. J Hypertens 1988,6:9−15.
- Imai Y, Abe K, Sasaki S et al. Daily variation of blood pressure in patients with Cushing’s syndrome. Tohoku J Exp Med VIF., 1987−153:67−74.
- Idema R, Gelsema E, Wenting G et al. Square wave fitting: a new method of characterizing diurinal variations in blood pressure. J Hypertens 1991−9:326−327
- Islim IF, Watson RD, Ihenacho H et al. Amlodipine: Effective for treatment of mild to moderate essential hypertension and left ventricular hypertrophy. Cardiology 2001−96:10−18.
- Yamazaki T, Komuro I, Yazaki Y Role of renin-angiotensin system in cardiac hypertrophy. Am J Cardiol 1999−83:53−57.
- Yudkin JS, Forrest RD, Baldari D et al. Microalbuminuria predicts cardiovascular disease in non-diabetic subgects: Islington Diabetes Survey. Lancet. 1988−2:530−533.
- Jensen JS, Borch JK, Jensen et al. Microalbuminuria reflects a generalized trans-vascular albumin leakiness in clinically healthy subject. Clin Sci Colch 1995−88:62 933.
- Jover B, Herizi A, Casellas D et al. Influence of irbesartan and enalapril on changes of renal function associated with the established phase of L-NAME hypertension. J Hypertens 2001:20:39−46.
- Kannel W Epidemiological implications of left ventricular hypertrophy. Left ventricular hypertrophy and its regression. Eds. By J. M Cruickshank, F.H. Messerli. London: Science Press, 1992:1−13
- Kannel W. Potency of vascular risk factors as the basis for antihypertensivetherapy. Framingham study. Europ. Heart J, 1992−13:34−42.
- Kapiotis S, Jilma B, Quehenberger P et al. Morning hypercoagulability and hy-pofibrinilysis: diurnal variations in circulating activated factor VII, protrombin flagement Fl+2, and plasmin-plasmin inhibitor complex. Circulation. 1997−96:19−21.
- Kario K, Matsuo T, Kobayashi H et al. Nocturnal fell of blood pressure and silent cerebrovascular damage in elderly patients: advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996−27:130−135.
- Koren MJ, Richard В Devereux, MD, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hipertension. Ann Intern Med 1991- 114: 345−352.
- Koren MJ, Ulin RJ, Laragh JH, Devereux RB. Changes in LVH predict risk in essential hypertension. Cerculation. l990−83(sappl):III-29.
- Krieg M, GunBer KI, Becrer H. J Clin Chem clin Biochem. 1986−24:863−69.
- Lacourciere Y, Poirier L, Cleroux j. Physical performance is preserved after regression of left ventricular hypertrophy. J Cardiovasc Pharmacol 1997−30−3:383−91.
- Laine H, Katoh С et al. Miocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and LVH. Circulation 1999−100:2425−2430.
- Leenen FH, Holliwell DL. Antihypertensive effect of felodipine assotiated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy. Am J Cardiol 1992−69:639−45.
- Levy D, Anderson KM, Savage DD, et al. Echocanjfogruphically detected LVH: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988-
- Levy D, Garrison RJ, Savage DD, Kannel, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990- 322: 1561- 1566.
- Liebson PR. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy. Am J Hypertens 1990- 3:512−517.
- Lievre M, Gueret P, Gayet С et al. Ramipril-induced regression of left ventricular hypertrophy in treated hypertensive individuals. Hypertension 1995−25:92−97.
- Litter W, West M, Honour A et al. The variability of arterial pressure. Am Heart J 1978−95:180−186.
- Lozance L, Zafirovska K, Bogdanovska S. Renal dysfunction and early differences in 24-hour ABPM in subjects predisposed for essential hypertension. Srp Arh Celok Lek 1996−124:197−9.
- Lorell ВН. Role of angiotensin ATI and AT2 receptors in cardiac hypertrophy and disease. Am J Cardiol 1999−83:48−52.
- Maiorano G. Et al. Evaluation of antihypertensive efficacy of losartan assessed by ABPM, hand grip test and echocardiographic study. Abstract. Glasgow. 23−27 June 1996 p. 1198.
- Madhavan S, Ooi WL, Cohen H et al. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994−23:395−401.
- MacKay JH, Aruri KE, Golberg AJ et al. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. Arch Intern Med. 1996- 156:278−285.
- Malaia I, Tkhostova E, Belousov Y. The influence of angiotensine II reseptor antagonist irbesartan on endothelial ftmction and diastolic function of left ventricle in patients with mild-to-moderate hypertension. J Hypertens 1999−17−3:254.
- Mallion JM, Baguet JP, Siche JP et al. Clinical value of ambulatory blood pressure monitoring. J Hypertens 1999−17:585−595.
- Mallion JM, Gaudemaris RD et al. Day and night blood pressure values in nor-motensive and essential hypertensive subjects assessed by twenty-four-hour ambulatory monitoring. J Hypertens 1990−8:49−55.
- Mancia G. Ambulatory blood pressure monitoring: research and clinical applications. J Hypertens, 1990,8:1−13.,
- Manchia G. Clinical use of ambulatory blood pressure. Am. J. Hypert. 1989−2:505−545.
- Mancia G et al. Blood pressure variability: mechanisms and clinical significance. J Cardiovasc. Pharmacol 1990−16:1−6.
- Mancia G et al. Effect of blood pressure measurement by the doctor on patient BP and heart rate. Lancet-1992:695−698.
- Mancia G, Giannottasio C, Omboni S. Ambulatory blood pressure monitoring and antihypertensive treatment. Europ Heart J, 1992−13 :43−47
- Mancia G, Ferrafi A, Gregorini L et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circulation research 1983−53:96−104.
- Mancia G, Parati G, Albini F et al. Circadian blood pressure variations and their impact on disease. J Cardiovasc Pharmacol 1988,12:11−17.
- Mancia G, Parati G, Omboni S et al. Ambulatory blood pressure monitoring. Clin Exp Hypertens 1999−21:703−715.
- Mancini GB. Hypertension, hypertrophy and the coronary circulation. Circulation 1991−83:89−96.
- Mattock MB, Morrish NJ, Viberti G et al. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992- 41:736−41.
- Mimran A, Ribstein J, Du Cailar G. Is microalbuminuria a marker of intrarenal vascular dysfunction in essential hypertension? Hypertension 1994- 223:1018−1021.
- Mogensen CE, Keane WF, Bennett Ш et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995- 346:1080−4.
- Mora B, Darwish A, Lederball О et al. Similar antitrophic effects of low- and high-dose ramipril on left ventricular hypertrophy in essential hypertension. Eur Heart J 1997−18:513.
- Muisan ML, Salvetti M, Rissoni D, Castellano M, Donato F, Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens. 1995−13:1091−1105.
- Muller J, Tofler G, Stone P. Circadian variation and triggers of onset of acute cardiovascular disiese. Circulation 1989 79−4:733−743.
- Muller-Brunotte, Eddner M, Malmqvist К et al. Reduced diastolic function in hypertensive left ventricular hypertrophy: improvement by ATl-blocade and beta-blocade. J Hypertens 1999−17,3:192.
- Moser M, Herbert P, Hennekens CR. An overview of the metaanalysis of the hypertension treatment trials. Arch Intern Med 1991 -151:1277−1279.
- Mulvany MJ, Hansen PK, Aalkjer С Direct evidence thet the greater contractility of resistance vessels in spontaneously hypertensive rat is associated with an increased number of smooth muscle cell layers. Circ Res 1978−43:854−64.
- Mc Lenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987−317:787−93.
- Mc Lenachan GM, Dargie HG A review of rhythm disorders in cardiac hypertrophy. Am J Cardiol 1990−65:42−44.mean and variability and severity of target-organ damage in hypertension. J Hypertens 1987−5:93−98.
- Parati O, Omboni B, Di Rienzo M et al. Twenty-four hour blood pressure variability: clinical implications. Kidney International. 1992.41:24−28.
- Parving HH Microalbuminuria in essential hypertension and diabetes mellitus. J of Hypertension 1996,14:89−94.
- Parving HH, Mogensen CE, Jensen HA et al. Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1974,1:1190−92.
- Pearson AP, Pasiercki T, Labovits AJ. Left ventricular hypertrophy, diagnosis, prognosis, management. Am Heart J 1991−121:148−157.
- Perloff D, Sokolow M, Cowan R et al. Prognostic value of ambulatory blood pressure monitoring in treated hypertensive patients. J. Hypertens, 1991,9:33−40.
- Pedrinelli R, Penno G, Dell Omo G, Bandinelli S. Microalbuminuria and transcapillary albumin leakage in essential hypertension. Hypertension. 1999−34:491−495.
- Perinotto P, Ragni G, Serventi M et al. Long-term effects of amlodipine on renal haemodynamics and microalbuminuria in patients with essential hypertension. Clin Drug Invest 1997Д3.36 -41.
- Perry HM, Miller JP, Fornoff JR et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension. 1995−25:587−594.
- Pfeffer MA, Pfeffer EM. Reversing cardiac hypertrophy in hypertension. N Engl J Med 1990- 322:1388−1390.
- Pickering G, Harshfield G, Devereux R et al. What is the role of ambulatory blood pressure monitoring in the managenent of hypertensive patients? Hypertension, 1985,7:171−177.
- Pickering TG, James GD. Determinants and consequences of the diurnal rhythm of blood pressure. Amer J Hypertens 1993,6:1665−1695.
- Pickering Th, Harshfield G, Blank S et al. Behavioral determinants of 24 hour blood pressure patterns in borderline hypertension. J Cardiovascul Pharmacol1986−8:589−592.
- Pierdomenico S, Lappena D, Cuccurullo F et al. Nighttime blood pressure pattern and miocardial ishemia in hypertensive patients with coronary artery disease. Abstr. 16 scientific meeting of the unternational society of hypertension. Glasgo.
- Pierdomenico S, Antidormi T Cuccurullo M et al. Hypertension and coronary artery disease: importance of circadian blood pressure rhythm for treatment strategy. Seventh European Meeting on Hypertension, Milan. 1995:150.
- Pohl M., Cooper M., Ukey J et al. Safety and efficacy of irbesartan in hypertensive patients with type II diabetes and proteinuria. Amer. J Hypertension, 1997-i0:105A (abstr.).
- Ponrtemoli R, Ravera M, Bezante GP et al. Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. J Hypertens 1999−17:993−1000.
- Potremoli R, Nicolella C, Viazzi f et al. Microalbuminuria in an early marker of target organ damage in essential hypertension. Am J Hypertens 1998−11:430−8.
- Prager G, Prager R, Klein P. Comparision of the twenty-four-hour blood pressure profile in elderly subjects with isolated systolic hypertension, essential hypertension and normotension. J of Hypertension. 1991:9.
- Prisant LM, Carrawith AA. Ambulatory blood pressure monitoring and echocar-diografic ventricular wall thickness and mass. Amer J Hypertens 1990−3:81−89.
- Purcell HJ, Gibbs SR, Coats AJ et al. Ambulatory blood pressure monitoring and circadian variation of cardiovascular disease- clinical and research applications. Intern J of Cardiology, 1992−36:135−149.
- Raij L Hypertension and cardiovascular risk factors: role of the angiotensin П-nitric oxide interaction. Hypertension 2001−37−2:767−73.
- Redon J, Gomez-Sanchez M, Baldo E et al. Microalbuminuria is correlated with left ventricular hypertrophy in male hypertensive patients. J Hypertens 1991 -9:148−149.
- Redon J, Baldo Б, Lurbe E et a). Microalbuminuria, left ventricular mass and ambulatory blood pressure in essential hypertension. Kidney int 1996−55:81−84.
- Redon J, Miralles A, Pascual JM et al. Hyperinsulinemia as a determinant of microalbuminuria in essential hypertension. J Hypertens 1997−15:79−86.
- Rocco MB, Валу J, Campbell S et al. Circadian variation of transient miocar-dial ischemia in patients with coronary artery disease. Circulation. l987−75:395−400.
- Romanova ТА, Dzumadulova AS, Mirrakhimov MM. Evaluation of the therapeutic effeciency of amlodipine in patients with essential hypertension. J Hypertens 1997−15−4:182.
- Rosansky S, Hoover D, King L et al. Rosansky S, Hoover D, King L et al. The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjiects. Arch Intern Med 1990,150:2073−2076.
- Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993−362:801−9.
- Ruilope LM, Guerrero L, Casal M et al. Tolerance to nitrendipine in patients with arterial hypertension accompanying chronic renal failure. J Cardiovasc Pharmacol 1991−18:71−3.
- Ruilope LM, Rodicio JL. Microalbuminuria in clinical practice. Kidney: a Current Survey of World Literature 1995−4:211−216.
- Ruilope LM, Alcazar JM, Rodicio JL: Renal conseguences of arterial hypertension. J Hypertens 1992−10:85−90.
- Savage DD, Garrison RJ, Kannel WB et al. The spectrum of LVH in a general population sample: the Framingham Study. Circulation 1987−75:26.
- Schlaich MP et al. Inadequate suppression of All modulates LV structure in humans. Clin Nephrol 1998−49:153−9.
- Scheuer J. Catecholamines in cardiac hypertrophy, Am J Cardiol 1999−83:70−74.
- Schillaci G, Verdecchia P, Porcellati C, et al. Continuous relation between LVM and cardiovascular risk in essential hypertension. Hypertension 2000−35:580−6.
- Schmieder et al. Reversal of LVH in essential hypertension: meta- analysis of randomized double-blind studies. JAMA 1996−275:1507−1513.
- Schlessinger SD, Tankersey MR, Crtis JJ. Clinical documentation or end-stage renal disease due to hypertension. Am J Kidney Dis 1994- 23:655−660.
- Schmieder RE, Velken R, Gatzka Ch D et al. Predictors for hypertensive heph-ropahy: results of a 6-year follow-up study in essential hypertension. J Hypertens. 1995, 13:357−365.
- Schulman DS, Flores AR, Tugoen J, Dianzumba S, Reichek N. Antihypertensive treatment in hypertensive patients with normal mass is associated with left ventricular remodeling and improved diastolic function. Am J Cardiol 1996- 78:56−60.
- Sica DA The importance of the sympathetic nervous system and systolic hypertension in patients with hypertension: benefits in treating patients with increased cardiovascular risk. Blood pressure monitoring 2000,5:19−25.
- Simone, GF Mureddu, R Greco, L Scalfi, AE del Puente, A Franzese, F Con-taldo, RB Devereux. Relation of left ventricular geometry and function to body composition in children with high causal blood pressure. Hypertention. 1997−30(part l)-377−382.
- Simone G, Greco R, Mureddu GF et al. Relation of left ventricular diastolic properties to systolic function in arterial hypertention. Circulation 2000−101:152−157.
- Smith DE, Ode HMO, Kernohom JW. Causes of death in hypertension. Am J Med 1950−9:516−527.
- Sokolow M, Werdegar S, Kain H et al. Relationship bitween level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation. 1966. 34:279−298.
- Somers V, Dyken M, Mark A et al. Autonomic and hemodynamic responses during sleep in normal and sleep-apneic humans. J Hypertens. 1992−10:4.
- Staessen JA, Bieniaszewski L, O’Brien et al. Nocturnal blood pressure fall on ambulatory monitoring in a large international database. Hypertens. 1997−29:30−39.
- Staessen SA, O’Brien ET, Amery AK et al. Ambulatory blood pressure in nor-motensive subjects: results from international database. Ibid 1994−12:7:l-2.
- Sumimoto T, Ochi T, Ito T et al. Both a calcium antagonist and ACE inhibitor reverse hypertrophy in hypertension but a calcium antagonist also depresses contractility. Cardiovascul Drugs and Therapy 1997- 11:27−32.
- Sutsch G., Boesiger P., Hess O.M. From left-ventricular hypertrophy to congestive heart failure. Schweizer Rundschau Medizin Praxis 1996−85:218−226.
- Sundberg S, Kohvakka A, Gordin A et al. Rapid reversal of circadian blood pressure rhythm in shift workers. J Hypertens 1988−6:393−396.
- Swynghedauw B. Remodellind of the heart in response to chronic mechanical overlead. Europ Heart J 1989−10:935−943.
- Tedesco M.A. Effects of Losartan on hypertention and left ventricular mass. A long-term study. Abstract: P 15.35 Amsterdam 7−11 June 1998.
- Toto R, Shultz P, Raij L. Eficacy and tolerability of losartan in hypertensive patients with renal impairment. Hypertension 1998−31−684−691.
- Tofler GH, Brezinski D, Schafer AJ et al. Concurrent morning increase in platelet aggregability and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987,316:1514−1518.
- Trimarco B, De Luca M, Ricciardelli В et al. Cardiac function in systemic hypertension befor and after reversal of left ventricular hypertrophy. Am J Cardiol 1988−62:745−50.
- Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialised countries since 1950. World Health Stat 1998−41:155−168.
- Unger T, Culman J, Gohlke P. Angiotensin II type I receptor blockade and end-organ protection: pharmacological rationale and evidence. J Hypertens 1998−16:3−9.
- VaJderrabano F, Jones E, Mallick N. Report of management of renal failure in Europe. Nephrol Dial Transplant 1995,10:1−25.
- Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001−141:334−41.
- Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 1995−26:1565−1574.
- Verdecchia P et al. Prognostic significance of serial changes in LV Mass in essential hypertension. Circulation 1998−97:48−54.
- Verdecchia P, Porcelatti C, Schilattci G et al. Ambulatory blood pressure an independent predictor of prognosis in essential hypertension. Hypertension 1994−24:793−801.
- Verdecchia P, Schillaci G, Gnerieri M et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990−81:528−536.
- Verdecchia P, Schillaci G, Bolderlini F et al. Risk stratification of left ventricular hypertrophy in systemic hypertension using noninvasive ambulatory blood pressure monitoring. Am J Cardiol 1990−66:583−590.
- Weber KT, Brilla CG,. Pathological hypertrophy and cardiac intersticium. Fibrosis and renin- angiotensin -aldosterone system. 1991- 83:1849−1865.
- Weber KT, Janicki JS, Angiotensin and the remodelling of myocardium. Brit J Clin Pharmacol 1989−28:141−150.
- Willich SN, Levy D, Rocco MB et al. Circadian variation in the incidence of sudden cardiac death in the Framinghamn Heart Study population. Am J Cardiol 1987−60:801−806.
- White W. Analysis of ambulatory blood pressure date in antihypertensive drug trials. J Hypertens 1991−9:27−32.
- White W, Morganroth J. Usfulness of ambulatory monitoring of blood pressure in assessing antihypertensive theory. Am J Cardiol 1989−63:94−98.
- White W, Schulman P, Mc. Cabe E et al. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989−261:873−877.
- White W. Accuracy and analysis of ambulatory blood pressure monitoring date. Clin Cardiolog. 1992−15:10−13.
- Witkowska M, Spring A, Kosmala et al. The effect of amlodipine on structure and function of the heart and exercise in patients with hypertension. Polskie Archi-vum medicyny wewnetrznej 19 997,40:333−42.
- Zachariah P. The role of ambulatory blood pressure monitoring in research. Clin Cardiol 1992−15:6−9.
- Zito M, Parati G, Omboni S et al. Effect of agein on blood pressure variability. J Hypertens 1991−9:328−329.
- Zucchelli P, Zuccala A, Gaggi R. Calcium channel blockers: effects on progressive renal disease. Am J Kidney Dis. 1991 -17:94−7.
- Melbume Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. BMJ 1991−302:210−6.
- Multiple risk factor intervention trail research group. MRF1T: Risk factor.
- Working Group Report. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure 1998.